• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Men's Health  • Prostate Disease  • Men's Health, Other  • Oncology  • Prostate Cancer  • Patient-Physician Communication  • Health Care Reform  • Alert me on articles by topic  Social Bookmarking   What's this?

Do Patients or Clinicians Have a Choice?

Steven H. Woolf, MD, MPH; Alex Krist, MD, MPH

Arch Intern Med. 2009;169(17):1557-1559.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The prostate-specific antigen (PSA) test was introduced in the late 1980s. Twenty years later there remains inadequate evidence about its benefits and harms when used for screening. The seriousness of the disease is unquestioned—prostate cancer claimed an estimated 28 660 lives in 2008¹—and the human toll impels the public, clinicians, and the public health community to act. However, evidence that early detection improves outcomes is scant, the often latent forms of the disease may pose little clinical threat to patients, false-positive results are common, and the harms and downstream consequences may outweigh the benefits.

THE RATIONALE FOR SHARED DECISION MAKING

The uncertain trade-offs and scant data have been the recurring concern of the US Preventive Services Task Force (USPSTF), which since 1989 has maintained that the evidence is insufficient to recommend for or against prostate cancer screening. (For men 75 years and older, the USPSTF has found . . . [Full Text of this Article]

SHARED DECISION MAKING IN PRACTICE

THE CHALLENGES TO SHARED DECISION MAKING

AUTHOR INFORMATION


CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Prostate Cancer Screening Decisions: Results From the National Survey of Medical Decisions (DECISIONS Study)
Richard M. Hoffman, Mick P. Couper, Brian J. Zikmund-Fisher, Carrie A. Levin, Mary McNaughton-Collins, Deborah L. Helitzer, John VanHoewyk, and Michael J. Barry
Arch Intern Med. 2009;169(17):1611-1618.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perineal discomfort in prostatic adenocarcinoma.
Giles
J R Soc Med Sh Rep 2010;1:38-38.
FULL TEXT